Rockville, MD (Jan. 8)—The US Food and Drug Administration approved 69 new drug applications (NDAs) last year, the second lowest number of approvals in the past decade, according to the Jan. 15 edition of Drug Industry Daily. The data, analyzed by the Friedman, Billings, Ramsey Group (FBR), show that the number of NDAs fell 26% from 93 approvals in 2006, and is 17% below the 10-year average of 83.4.

Link to Article

Pharmaceutical Technology, Advanstar Communications Inc.

16/01/2008 - The European Commission has launched an investigation into the entire European pharmaceutical sector, with surprise raids on a number of manufacturers in a bid to unearth any evidence of foul-play hampering the launch of new medicines on the market.

Link to Article

in-pharmatechnologist.com

17/01/2008 - Outsourcing will be seen as being "instrumental" in the eyes of healthcare and biopharma firms this year as the focus on cost reduction continues to increase, according to a new report.

Link to Article

in-pharmatechnologist.com